Jun 2020 $14 M Private placement after listing $10 to $50 million 3
TrovaGene Inc.: Private sale, Jun 2020 × Investors in this round 3 investors had bought by the notice of Jun 23, 2020: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $14 M of $14 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Mark S. Erlander · Executive Officer, Director · Chief Executive Officer Gary Jacob · Director Gary W. Pace · Director James O. Armitage · Director John W. Brancaccio · Director Lale O. White · Director Rodney S. Markin · Director Thomas Adams · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Erlander, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 23, 2020. Read the notice at the SEC .
equity, options SEC May 2020 $3 M Private placement after listing $2 to $10 million 1
TrovaGene Inc.: Private sale, May 2020 × Investors in this round 1 investor had bought by the notice of Jun 1, 2020: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Mark S. Erlander · Executive Officer Gary Jacob · Director Gary W. Pace · Director James O. Armitage · Director John W. Brancaccio · Director Lale O. White · Director Rodney S. Markin · Director Thomas Adams · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Mark Erlander, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 1, 2020. Read the notice at the SEC .
equity, options SEC Mar 2020 $2 M Private placement after listing $2 to $10 million 1
TrovaGene Inc.: Private sale, Mar 2020 × Investors in this round 1 investor had bought by the notice of Apr 14, 2020: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Thomas Adams · Executive Officer, Director Gary Jacob · Director Gary W. Pace · Director James O. Armitage · Director John W. Brancaccio · Director Lale O. White · Director Mark S. Erlander · Director Rodney S. Markin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas Adams, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 14, 2020. Read the notice at the SEC .
equity, options SEC Oct 2019 $5 M Private placement after listing $2 to $10 million 2
TrovaGene Inc.: Private sale, Oct 2019 × Investors in this round 2 investors had bought by the notice of Oct 30, 2019: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,150,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Brigitte H. Lindsay · Executive Officer Thomas H. Adams · Executive Officer, Director Athena S. Countouriotis · Director Gary S. Jacob · Director John P. Brancaccio · Director Rodney S. Markin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in IL, NY Remarks in the notice On fees: “Includes a cash fee of 7.5% of the aggregate gross proceeds raised in the offering including gross proceeds received from the cash exercise of warrants issued in the offering together with other expense reimbursement.”Signed by Thomas H. Adams, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 30, 2019. Read the notice at the SEC .
equity, options SEC Aug 2019 $2 M Private placement after listing Under $2 million 1
TrovaGene Inc.: Private sale, Aug 2019 × Investors in this round 1 investor had bought by the notice of Aug 28, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Thomas Adams · Executive Officer, Director Athena S. Countouriotis · Director Gary Jacob · Director John S. Brancaccio · Director Rodney S. Markin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas Adams, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 28, 2019. Read the notice at the SEC .
equity, options SEC May 2019 $2 M Private placement after listing Under $2 million 1
TrovaGene Inc.: Private sale, May 2019 × Investors in this round 1 investor had bought by the notice of May 20, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Thomas Adams · Executive Officer, Director Athena S. Countouriotis · Director Gary Jacob · Director John S. Brancaccio · Director Rodney S. Markin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas Adams, Chief Executive Officer. Source: SEC Form D, newest notice filed May 20, 2019. Read the notice at the SEC .
equity, options SEC Apr 2019 $2 M Private placement after listing Under $2 million 1
TrovaGene Inc.: Private sale, Apr 2019 × Investors in this round 1 investor had bought by the notice of Apr 10, 2019: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Thomas Adams · Executive Officer, Director Athena S. Countouriotis · Director Gary Jacob · Director John S. Brancaccio · Director Rodney S. Markin · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas Adams, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 10, 2019. Read the notice at the SEC .
equity, options SEC Nov 2012 $4 M No. 2 $2 to $10 million 8
TrovaGene Inc.: Raise no. 2, Nov 2012 × Investors in this round 8 investors had bought by the notice of Dec 7, 2012: 8 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Antonius Schuh · Executive Officer, Director Steve Zaniboni · Executive Officer Gabriele Cerrone · Director Gary Jacob · Director John Brancaccio · Director Stanley Tennant · Director Thomas Adams · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Antonius Schuh, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 7, 2012. Read the notice at the SEC .
equity, options SEC Jun 2009 $7 M No. 1 $2 to $10 million 40
TrovaGene Inc.: Raise no. 1, Jun 2009 × Investors in this round 40 investors had bought by the notice of Mar 26, 2012: 40 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities
Meant to last more than a year
Issuer's revenue Up to $1 million
Sales commissions $124,500
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Antonius Schuh · Executive Officer, Director David Robbins · Executive Officer Steve Zanibobi · Executive Officer Gabriele Cerrone · Director Gary Jacob · Director John Brancaccio · Director Stanley Tennant · Director Thomas Adams · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On fees: “The above amount represents cash component of sales commissions paid to foreign selling agent. In addition, equity compensation also paid.”On the use of proceeds: “Issuer used proceeds from the offering for working capital purposes which included payment of salaries to named executive officers.”Signed by /s/ Antonius Schuh, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 26, 2012. Read the notice at the SEC .
equity, options SEC